Dr. David Reardon, MD
Claim this profileDana Farber Cancer Institute
Studies Glioblastoma
Studies Brain Tumor
12 reported clinical trials
16 drugs studied
Area of expertise
1Glioblastoma
IDH positive
Stage IV
MET negative
2Brain Tumor
Stage IV
IDH positive
NTRK positive
Affiliated Hospitals
Clinical Trials David Reardon, MD is currently running
Nivolumab Safety
for Cancer
Main Objective of this study is to examine long-term safety of nivolumab monotherapy including combinations and other cancer therapies in various tumor types.
Recruiting1 award Phase 2
Safusidenib
for Brain Cancer
This trial is testing a new oral medication called safusidenib for patients with certain types of brain tumors that have not responded to other treatments. The drug works by targeting a specific gene mutation to slow down tumor growth. The study will evaluate the safety and effectiveness of different doses of the medication.
Recruiting0 awards Phase 220 criteria
More about David Reardon, MD
Clinical Trial Related2 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments David Reardon, MD has experience with
- Temozolomide
- Nivolumab
- Pembrolizumab
- Personalized NeoAntigen Vaccine
- Radiation Therapy
- External Beam RT
Breakdown of trials David Reardon, MD has run
Glioblastoma
Brain Tumor
Brain Cancer
Follicular Lymphoma
Meningioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Reardon, MD specialize in?
David Reardon, MD focuses on Glioblastoma and Brain Tumor. In particular, much of their work with Glioblastoma has involved IDH positive patients, or patients who are Stage IV.
Is David Reardon, MD currently recruiting for clinical trials?
Yes, David Reardon, MD is currently recruiting for 3 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that David Reardon, MD has studied deeply?
Yes, David Reardon, MD has studied treatments such as Temozolomide, Nivolumab, Pembrolizumab.
What is the best way to schedule an appointment with David Reardon, MD?
Apply for one of the trials that David Reardon, MD is conducting.
What is the office address of David Reardon, MD?
The office of David Reardon, MD is located at: Dana Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.